Product Reports Resources Pricing Login Book a demo

Carlsmed

Biotech & Life Sciences · United States · Founded 2018 · IPO 2025

Carlsmed operates in the medical technology sector, focusing on personalized spine surgery solutions. The company leverages patient data and advanced digital technologies to create customized surgical plans and 3D-printed spine fusion devices, known as aprevo implants. These implants are tailored to each patient's unique anatomical needs, ensuring optimal surgical outcomes. Carlsmed serves healthcare professionals, particularly spine surgeons, and their patients who require spine fusion surgeries. The business model revolves around the integration of patient imaging data, surgeon preferences, and digital design to produce bespoke surgical solutions. Revenue is generated through the sale of these personalized implants and associated surgical planning services. By providing highly customized medical devices, Carlsmed aims to improve surgical precision and patient recovery times. Keywords: personalized spine surgery, 3D-printed implants, patient-specific plans, digital technologies, spine fusion devices, healthcare professionals, surgical precision, medical technology, patient data, bespoke surgical solutions.

Valuation $262M
Revenue $75M
Total funding $50–100M
Power Law Colt$25–100M revenue

Investors

6 investors on Carlsmed's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 2 investors entered at this stage
The Cove Fund
Wavemaker Three-Sixty Health
Series A 3 investors entered at this stage
U.S. Venture Partners
The Vertical Group
B Capital
Series B+ 1 investor entered at this stage
Customers Bank

Global footprint

Where Carlsmed has talent and traffic

Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown
Web traffic by country
6.9K monthly visits
across markets
🇺🇸 United States85.5%
🇮🇳 India14.5%
Top 2 markets shown

Talent graph

The shape of Carlsmed's talent

Dealroom maps Carlsmed's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

9 standout operatorsDealroom-flagged across the org
1 AI specialistincl. 1 core researchers
148 employees mappedperson by person
DimensionScore
AI Talentlive Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Carlsmed's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about Carlsmed

An AI-synthesized read of the highest-engagement posts about Carlsmed on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Carlsmed on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles